Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
None listed
Sponsors
Ayurswasthya Yojana, Centre of excellence Scheme, Ministry of Ayush, Govt of India
Eligibility
Inclusion criteria
Inclusion criteria: i. Clinically diagnosed adult cases of any gender diagnosed with type 2 diabetes (with or without treatment) ii. Subjects who agree to participate in the study and submit a written informed consent form.
Exclusion criteria
Exclusion criteria: i. Subject diagnosed with type 1 Diabetes Mellitus ii. Subject on systemic or oral steroids iii. Pregnant /lactating women iv. Subjects with a current diagnosis of malignancy or in the last five years or who has undergone chemotherapy v. Subjects with any other neurological diseases or nerve dysfunction that may interfere with the study or receiving any treatment that might influence nerve function vi. Subjects with history /current diagnosis of vitamin B12 deficiency/megaloblastic anaemia vii. Subjects with history/current diagnosis of hypothyroidism viii. Subjects with history/current diagnosis of autoimmune diseases ix. Any other condition that the Investigator thinks may jeopardize the safety of the subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i. Estimation of occurrence of diabetic peripheral neuropathy among type 2 diabetic patients ii. Relationship between diabetic peripheral neuropathy (DPN) and Prakriti among type 2 diabetic patientsTimepoint: One time assessment at enrolment | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between age and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;ii. Relationship between gender and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;iii. Relationship between family history and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;iv. Relationship between glycosylated hemoglobin and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;v. Relationship between chronicity of diabetes and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;vi. Relationship between body mass index (BMI) and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;vii. Relationship between addictions and diabetic peripheral neuropathy among type 2 diabetic patientsTimepoint: One time assessment at enrolment;vii. Determination and classification of the risk for diabetic foot ulceration and amputation among type 2 diabetic patientsTimepoint: One time assessment at enrolment | — |
Countries
India
Contacts
Public ContactDr Vidyashree Anchan Vitthal
Central Ayurveda Research Institute
Outcome results
None listed